Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Fernandes (Matosinhos, Portugal), M. Dias (Vila Nova de Gaia, Portugal), A. Alves (Vila Nova de Gaia, Portugal), D. Coutinho (Vila Nova de Gaia, Portugal), E. Silva (Vila Nova de Gaia, Portugal), T. Costa (Vila Nova de Gaia, Portugal), S. Campainha (Vila Nova de Gaia, Portugal), S. Conde (Vila Nova de Gaia, Portugal), A. Barroso (Vila Nova de Gaia, Portugal). Response to Immunotherapy in non-small cell lung cancer: the effect of weight. 1738

Member's Comments

No comment yet.

Related content which might interest you: Targeted therapy in non-small cell lung cancer Source: Breathe 2012; 8: 206-215 Year: 2012 Anticancer treatment for advanced non-small cell lung cancer Source: Breathe 2011; 8: 124-133 Year: 2011 Metastatic disease in non-small cell lung cancer: is it all the same? Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017 Response to chemotherapy as a predictor of survival in advanced non-small cell lung cancer (NSCLC) Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Update on nonsmall cell lung cancer Source: Eur Respir Rev 2010 19: 173-185 Year: 2010 Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm Source: Eur Respir J, 55 (2) 1901907; 10.1183/13993003.01907-2019 Year: 2020 XAGE-1b and p53: Potential targets for immunotherapy of non-small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Proliferative activity of non-small cell lung cancer after induction chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 328s Year: 2005 Chemotherapy toxicity in advanced non-small cell lung cancer and its impact on survival Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Changes in lymphocyte subgroups of non-small cell lung cancer patients during chemotherapy Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Non-small cell lung cancer with single brain metastasis: the role of surgical treatment Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008 Changes of lung function in patients with non-small cell lung cancer tretaed by chemotherapy Source: Eur Respir J 2006; 28: Suppl. 50, 771s Year: 2006 Breast metastasis in association with non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 538s Year: 2005 Second line therapy for advanced non-small cell lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Effect of comorbidity on the prognosis of non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 385s Year: 2006 Treatment of  non-small cell lung cancer (NSCLC) - the state of the art and beyond Source: International Congress 2017 – State of the art session: "Lung cancer" Year: 2017 Biological therapies in nonsmall cell lung cancer Source: Eur Respir J , 49 (3) 1601520; DOI: 10.1183/13993003.01520-2016 Year: 2017 Physical Activity patients following lung resection for non-small cell lung cancer Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases Year: 2017